2024 has been a year of exciting developments in obesity medicine, bringing new hope and possibilities for individuals living with this chronic condition. Here are the top five advancements that could shape how we care for people with obesity:
Organisations like the World Health Organisation (WHO) are highlighting that obesity is a complex, chronic disease influenced by genetics, biology, and environment—not just personal choices. Many countries are working on public education campaigns and improving access to medical care for obesity. This change could help reduce stigma and make it easier to access treatments without feeling judged.
Research is uncovering the intricate relationship between obesity and other health issues, such as type 2 diabetes, heart disease and cancer. This knowledge helps healthcare professionals provide more comprehensive care and address the root causes of these interconnected health problems.
The development of new medications targeting gut hormones like GLP-1 and GIP has shown remarkable results in clinical trials. These medications not only suppress appetite but also improve metabolic function, leading to significant and sustained weight loss and improvements in overall health.
The goal of obesity treatment is moving from solely weight loss to improving overall health and well-being. This includes reducing the risk of complications such as type 2 diabetes, heart disease, and certain types of cancer, as well as enhancing your quality of life. For example, studies have shown that Wegovy (Semaglutide) can improve cardiovascular and renal health, and Tirzepatide (Mounjaro) can significantly reduce the risk of developing type 2 diabetes and improve obstructive sleep apnoea.
Advancements in minimally invasive bariatric procedures, such as endoscopic sleeve gastroplasty (ESG), have made surgical options safer and more accessible. These procedures require no major incisions and have shorter recovery times.
What’s next in managing obesity? As we look forward to 2025, even more exciting developments are on the horizon:
Further advancements in drug therapies
The development of new medications for obesity will continue, with a focus on improving efficacy, safety and convenience. We can also expect to see more combination therapies that combine medications with other interventions like lifestyle changes or even surgery, aiming for even greater weight loss and metabolic health benefits.
Focus on Prevention
While treatment is essential, preventing obesity is also key. In 2025, we may see more public health initiatives aimed at promoting healthy lifestyles, particularly in children and adolescents.
Increased use of technology
Technology will play a greater role in obesity treatment, with the use of wearable devices, mobile apps, and telehealth to monitor patients, provide support, and deliver interventions remotely.
Expanded access to care
Expect more policies aimed at increasing access to obesity care globally. In the UK, the NHS is expected to fund more community-level interventions, such as local weight loss programmes, and expand access to obesity management medications.
Precision Medicine
Recognising that obesity is a complex condition with various underlying causes, there has been a growing interest in personalised treatment approaches. Advances in assessments and investigations could identify subtypes of obesity and allow a tailored treatment plan aligned with your unique biology.
Final Thoughts
Overall, the future of obesity treatment looks promising, with new advancements and a growing understanding of this complex condition. As we enter 2025, the combination of innovative treatments, personalised care and improved accessibility holds the promise of a healthier future for people living with obesity.